Literature DB >> 7406929

A controlled study of plasma exchange in the treatment of severe rheumatoid arthritis.

R S Rothwell, P Davis, P A Gordon, M K Dasgupta, K V Johny, A S Russell, J S Percy.   

Abstract

To learn whether the removal of immune complexes from the circulation by plasma exchange could effect an improvement in disease activity in rheumatoid arthritis (RA) patients, we performed a controlled study of 20 patients, we performed a controlled study of 20 patients with severe progressive disease which had not responded to previous therapy. Ten patients (Group 1) were hospitalized, continued on their regular anti-inflammatory medication, and given a graded course of physiotherapy. A further 10 patients (Group 2) received the same treatment as the first group with the addition of a concurrent course of plasmapheresis. Clinical measurement of disease activity after treatment revealed little difference between the two groups with a statistically significant improvement in four measures in Group 1 and in five in Group 2. Laboratory studies suggested that the intensity of plasma exchange was sufficient to remove circulating immune complexes in these patients. Our results confirm that hospitalization in itself is of benefit in the treatment of acute exacerbations of rheumatoid arthritis. The marginal improvement achieved by the addition of plasma exchange in the management of these patients (despite the removal of circulating immune complexes) makes its short-term use of questionable value in the treatment of severe rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7406929     DOI: 10.1002/art.1780230702

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

Review 1.  Treatment of severe rheumatoid arthritis.

Authors:  V Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-15

Review 2.  Potential for plasma exchange in children.

Authors:  E A Robinson
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

3.  Where now for therapeutic apheresis?

Authors:  T Hamblin
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-29

4.  Plasmapheresis in clinical medicine.

Authors:  C Linker
Journal:  West J Med       Date:  1983-01

5.  Apheresis therapy: spin-drying the blood.

Authors:  T J Hamblin
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-23

6.  Apheresis enhances the selective removal of antinuclear antibodies in systemic lupus erythematosus.

Authors:  K K Colburn; G A Gusewitch; B S Statian Pooprasert; R H Weisbart
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

Review 7.  The optimum management of arthropathies.

Authors:  C S Wolfe; G R Hughes
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

8.  Extracorporeal hydrophobic amino acid adsorbent therapy in rheumatoid arthritis.

Authors:  K Takahashi; S Yoshinoya; H Yoshizawa; T Miyamoto
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.